These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7623237)

  • 1. Neuroblastoma in infants aged less than 6 months: is more aggressive treatment necessary? A report from the Pediatric Oncology Study Group of the Kyushu area.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ogami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S
    J Pediatr Surg; 1995 May; 30(5):715-21. PubMed ID: 7623237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to deal with advanced cases of neuroblastoma detected by mass screening: a report from the Pediatric Oncology Study Group of the Kyushu area of Japan.
    Suita S; Zaizen Y; Yano H; Akiyama H; Sera Y; Takamatsu H; Ueda K; Tasaka H; Miyazaki S; Kawakami K
    J Pediatr Surg; 1994 May; 29(5):599-603. PubMed ID: 8035266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J
    J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
    Minard V; Hartmann O; Peyroulet MC; Michon J; Coze C; Defachelle AS; Lejars O; Perel Y; Bergeron C; Boutard P; Leverger G; Stephan JL; Thyss A; Chastagner P; Couillault G; Devalck C; Lutz P; Mechinaud F; Millot F; Plantaz D; Rialland X; Rubie H
    Br J Cancer; 2000 Oct; 83(8):973-9. PubMed ID: 10993641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma.
    De Bernardi B; Pianca C; Boni L; Brisigotti M; Carli M; Bagnulo S; Corciulo P; Mancini A; De Laurentis C; Di Tullio MT
    Cancer; 1992 Sep; 70(6):1625-33. PubMed ID: 1516016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
    Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and prognosis in neuroblastoma. Review of 112 patients younger than 2 years.
    Jereb B; Bretsky SS; Vogel R; Helson L
    Am J Pediatr Hematol Oncol; 1984; 6(3):233-43. PubMed ID: 6517224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
    J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of the usefulness of screening for neuroblastoma.
    Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
    Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
    Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma.
    De Bernardi B; Conte M; Mancini A; Donfrancesco A; Alvisi P; Tomà P; Casale F; Cordero di Montezemolo L; Cornelli PE; Carli M
    J Clin Oncol; 1995 Apr; 13(4):884-93. PubMed ID: 7707115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
    Suita S
    J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
    Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
    Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up results of the observation program for neuroblastoma detected at 6-month mass screening.
    Arakawa A; Oguma E; Aihara T; Kishimoto H; Kikuchi A; Hanada R; Koh K
    J Pediatr; 2014 Oct; 165(4):855-7.e1. PubMed ID: 25091258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.